The Exonuclease Trex2 Shapes Psoriatic Phenotype

Journal of Investigative Dermatology

Volumn 136, Issue 12, 2016, Pages 2345-2355

  Manils, Joan ^a   Casas, Eduard ^b,c   Viña Vilaseca, Arnau ^a   López Cano, Marc ^a   Díez Villanueva, Anna ^b   Gómez, Diana ^a   Marruecos, Laura ^a   Ferran, Marta ^d   Benito, Carmen ^a   Perrino, Fred W ^e   Vavouri, Tanya ^b,c   de Anta, Josep Maria ^a   Ciruela, Francisco ^a   Soler, Concepció ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institute for Predictive and Personalized Medicine of Cancer (IMPPC)   (Spain)

^c JOSEP CARRERAS LEUKAEMIA RESEARCH INSTITUTE IJC   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXONUCLEASE; IMIQUIMOD; INTERLEUKIN 23; PROTEIN TREX2; TRANSCRIPTOME; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; EXODEOXYRIBONUCLEASE; TREX2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; DEREGULATION; DERMATITIS; DNA DEGRADATION; DNA REPAIR; DOWN REGULATION; EAR SWELLING; ENUCLEATION; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERKERATOSIS; IMMUNE RESPONSE GENE; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; PARAKERATOSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; STRATUM CORNEUM; SWELLING; UPREGULATION; WILD TYPE; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

AMINOQUINOLINES; ANIMALS; APOPTOSIS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXODEOXYRIBONUCLEASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MICE, KNOCKOUT; PHENOTYPE; PROGNOSIS; PSORIASIS; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84997235079     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.05.122     Document Type: Article

References (73)

1. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25 (2000), 25–29.
2. Aubert, M., Boyle, N.M., Stone, D., Stensland, L., Huang, M.L., Magaret, A.S., et al. In vitro inactivation of latent HSV by targeted mutagenesis using an HSV-specific homing endonuclease. Mol Ther Nucleic Acids, 3, 2014, e146.
3. Baritaud, M., Boujrad, H., Lorenzo, H.K., Krantic, S., Susin, S.A., Histone H2AX: the missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle 9 (2010), 3166–3173.
4. Bennardo, N., Gunn, A., Cheng, A., Hasty, P., Stark, J.M., Limiting the persistence of a chromosome break diminishes its mutagenic potential. PLoS Genet, 5, 2009, e1000683.
5. Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35 (2011), 596–610.
6. Chan, M.P., Onji, M., Fukui, R., Kawane, K., Shibata, T., Saitoh, S., et al. DNase II-dependent DNA digestion is required for DNA sensing by TLR9. Nat Commun, 6, 2015, 5853.
7. Chen, M.J., Ma, S.M., Dumitrache, L.C., Hasty, P., Biochemical and cellular characteristics of the 3' → 5' exonuclease TREX2. Nucleic Acids Res 35 (2007), 2682–2694.
8. Chiliveru, S., Rahbek, S.H., Jensen, S.K., Jørgensen, S.E., Nissen, S.K., Christiansen, S.H., et al. Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA. J Immunol 192 (2014), 2395–2404.
9. Cua, D.J., Tato, C.M., Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10 (2010), 479–489.
10. de Silva, U., Perrino, F.W., Hollis, T., DNA binding induces active site conformational change in the human TREX2 3'-exonuclease. Nucleic Acids Res 37 (2009), 2411–2417.
11. Demaria, O., Di Domizio, J., Gilliet, M., Immune sensing of nucleic acids in inflammatory skin diseases. Semin Immunopathol 36 (2014), 519–529.
12. Di Cesare, A., Di Meglio, P., Nestle, F.O., The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129 (2009), 1339–1350.
13. Dombrowski, Y., Peric, M., Koglin, S., Kammerbauer, C., Göss, C., Anz, D., et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med, 3, 2011, 82ra38.
14. Eckhart, L., Lippens, S., Tschachler, E., Declercq, W., Cell death by cornification. Biochim Biophys Acta 1833 (2013), 3471–3480.
15. El Malki, K., Karbach, S.H., Huppert, J., Zayoud, M., Reissig, S., Schüler, R., et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol 133 (2013), 441–451.
16. Fischer, H., Eckhart, L., Mildner, M., Jaeger, K., Buchberger, M., Ghannadan, M., et al. DNase1L2 degrades nuclear DNA during corneocyte formation. J Invest Dermatol 127 (2007), 24–30.
17. Fischer, H., Szabo, S., Scherz, J., Jaeger, K., Rossiter, H., Buchberger, M., et al. Essential role of the keratinocyte-specific endonuclease DNase1L2 in the removal of nuclear DNA from hair and nails. J Invest Dermatol 131 (2011), 1208–1215.
18. Flutter, B., Nestle, F.O., TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol 43 (2013), 3138–3146.
19. Fuchs, E., Scratching the surface of skin development. Nature 445 (2007), 834–842.
20. Gall, A., Treuting, P., Elkon, K.B., Loo, Y.M., Gale, M. Jr., Barber, G.N., et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36 (2012), 120–131.
21. Gehrke, N., Mertens, C., Zillinger, T., Wenzel, J., Bald, T., Zahn, S., et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39 (2013), 482–495.
22. Gilliet, M., Lande, R., Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol 20 (2008), 401–407.
23. Glitzner, E., Korosec, A., Brunner, P.M., Drobits, B., Amberg, N., Schonthaler, H.B., et al. Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Mol Med 6 (2014), 1312–1327.
24. Grieves, J.L., Fye, J.M., Harvey, S., Grayson, J.M., Hollis, T., Perrino, F.W., Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci USA 112 (2015), 5117–5122.
25. Guttman-Yassky, E., Suárez-Fariñas, M., Chiricozzi, A., Nograles, K.E., Shemer, A., Fuentes-Duculan, J., et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 124 (2009), 1235–1244.e58.
26. Hara-Chikuma, M., Satooka, H., Watanabe, S., Honda, T., Miyachi, Y., Watanabe, T., et al. Aquaporin-3-mediated hydrogen peroxide transport is required for NF-kB signalling in keratinocytes and development of psoriasis. Nat Commun, 6, 2015, 7454.
27. Hu, L., Kim, T.M., Son, M.Y., Kim, S.A., Holland, C.L., Tateishi, S., et al. Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes. Nature 501 (2013), 569–572.
28. Joshi-Tope, G., Gillespie, M., Vastrik, I., D'Eustachio, P., Schmidt, E., de Bono, B., et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 33 (2005), D428–D432.
29. Kawane, K., Fukuyama, H., Kondoh, G., Takeda, J., Ohsawa, Y., Uchiyama, Y., et al. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292 (2001), 1546–1549.
30. Kawane, K., Fukuyama, H., Yoshida, H., Nagase, H., Ohsawa, Y., Uchiyama, Y., et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat Immunol 4 (2003), 138–144.
31. Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006), 998–1002.
32. Kumari, S., Redouane, Y., Lopez-Mosqueda, J., Shiraishi, R., Romanowska, M., Lutzmayer, S., et al. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. Elife, 3, 2014, e03422.
33. Lan, Y.Y., Londono, D., Bouley, R., Rooney, M.S., Hacohen, N., Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. Cell Rep 9 (2014), 180–192.
34. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.H., Homey, B., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449 (2007), 564–569.
35. Lee, H.M., Yuk, J.M., Shin, D.M., Yang, C.S., Kim, K.K., Choi, D.K., et al. Apurinic/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses. J Immunol 183 (2009), 6839–6848.
36. Li, B., Tsoi, L.C., Swindell, W.R., Gudjonsson, J.E., Tejasvi, T., Johnston, A., et al. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol 134 (2014), 1828–1838.
37. Liao, Y., Smyth, G.K., Shi, W., featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30 (2014), 923–930.
38. Lin, A.M., Rubin, C.J., Khandpur, R., Wang, J.Y., Riblett, M., Yalavarthi, S., et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187 (2011), 490–500.
39. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 15, 2014, 550.
40. Lowes, M.A., Suarez-Farinas, M., Krueger, J.G., Immunology of psoriasis. Annu Rev Immunol 32 (2014), 227–255.
41. Lu, C., Zhu, F., Cho, Y.Y., Tang, F., Zykova, T., Ma, W.Y., et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 23 (2006), 121–132.
42. Manils, J., Gomez, D., Salla-Martret, M., Fischer, H., Fye, J.M., Marzo, E., et al. Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis. Oncotarget 6 (2015), 22375–22396.
43. Mazur, D.J., Perrino, F.W., Excision of 3' termini by the Trex1 and TREX2 3'–>5' exonucleases. Characterization of the recombinant proteins. J Biol Chem 276 (2001), 17022–17029.
44. Merico, D., Isserlin, R., Stueker, O., Emili, A., Bader, G.D., Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One, 5, 2010, e13984.
45. Naeem, A.S., Zhu, Y., Di, W.L., Marmiroli, S., O'Shaughnessy, R.F., AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation. Cell Death Differ 22 (2015), 2123–2132.
46. Nair, R.P., Duffin, K.C., Helms, C., Ding, J., Stuart, P.E., Goldgar, D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41 (2009), 199–204.
47. Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H.G., Möröy, T., Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25 (2000), 177–181.
48. Nestle, F.O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202 (2005), 135–143.
49. Paludan, S.R., Activation and regulation of DNA-driven immune responses. Microbiol Mol Biol Rev 79 (2015), 225–241.
50. Panayotova-Dimitrova, D., Feoktistova, M., Ploesser, M., Kellert, B., Hupe, M., Horn, S., et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep 5 (2013), 397–408.
51. Parra, D., Manils, J., Castellana, B., Viña-Vilaseca, A., Morán-Salvador, E., Vázquez-Villoldo, N., et al. Increased susceptibility to skin carcinogenesis in TREX2 knockout mice. Cancer Res 69 (2009), 6676–6684.
52. Pasparakis, M., Haase, I., Nestle, F.O., Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 14 (2014), 289–301.
53. Perrino, F.W., de Silva, U., Harvey, S., Pryor, E.E. Jr., Cole, D.W., Hollis, T., Cooperative DNA binding and communication across the dimer interface in the TREX2 3' → 5'-exonuclease. J Biol Chem 283 (2008), 21441–21452.
54. Perrino, F.W., Harvey, S., McMillin, S., Hollis, T., The human TREX2 3' → 5'-exonuclease structure suggests a mechanism for efficient nonprocessive DNA catalysis. J Biol Chem 280 (2005), 15212–15218.
55. Reischl, J., Schwenke, S., Beekman, J.M., Mrowietz, U., Stürzebecher, S., Heubach, J.F., Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol 127 (2007), 163–169.
56. Rickard, J.A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. Elife, 3, 2014, e10592.
57. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., Bonner, W.M., DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273 (1998), 5858–5868.
58. Schon, M.P., Wienrich, B.G., Drewniok, C., Bong, A.B., Eberle, J., Geilen, C.C., et al. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol 122 (2004), 1266–1276.
59. Schonthaler, H.B., Guinea-Viniegra, J., Wculek, S.K., Ruppen, I., Ximénez-Embún, P., Guío-Carrión, A., et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity 39 (2013), 1171–1181.
60. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13 (2003), 2498–2504.
61. Stetson, D.B., Ko, J.S., Heidmann, T., Medzhitov, R., Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134 (2008), 587–598.
62. Swindell, W.R., Johnston, A., Carbajal, S., Han, G., Wohn, C., Lu, J., et al. Genome-Wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS ONE, 6, 2011, e18266.
63. Suarez-Farinas, M., Li, K., Fuentes-Duculan, J., Hayden, K., Brodmerkel, C., Krueger, J.G., Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132 (2012), 2552–2564.
64. Suárez-Fariñas, M., Arbeit, R., Jiang, W., Hayden, K., Brodmerkel, C., Krueger, J.G., Suppression of molecular inflammatory pathways by toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation. PLoS One, 12, 2013, e84634.
65. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102 (2005), 15545–15550.
66. van der Fits, L., Mourits, S., Voerman, J.S., Kant, M., Boon, L., Laman, J.D., et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182 (2009), 5836–5845.
67. Wagner, E.F., Schonthaler, H.B., Guinea-Viniegra, J., Tschachler, E., Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6 (2010), 704–714.
68. Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, et al. gplots: various R programming tools for plotting data. R package version 2.17.0, https://cran.r-project.org/src/contrib/Archive/gplots/gplots_2.17.0.tar.gz 2015 (accessed 2 May 2015).
69. Wohn, C., Ober-Blobaum, J.L., Haak, S., Pantelyushin, S., Cheong, C., Zahner, S.P., et al. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc Natl Acad Sci USA 110 (2013), 10723–10728.
70. Yamamoto-Tanaka, M., Makino, T., Motoyama, A., Miyai, M., Tsuboi, R., Hibino, T., Multiple pathways are involved in DNA degradation during keratinocyte terminal differentiation. Cell Death Dis, 5, 2014, e1181.
71. Yang, Y.G., Lindahl, T., Barnes, D.E., Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131 (2007), 873–886.
72. Yao, Y., Richman, L., Morehouse, C., de los Reyes, M., Higgs, B.W., Boutrin, A., et al. Type I interferon: potential therapeutic target for psoriasis?. PLoS One, 3, 2008, e2737.
73. Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H., Nagata, S., Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 6 (2005), 49–56.